138 related articles for article (PubMed ID: 25992779)
1. Feasibility and Safety of Local Treatment with Recombinant Human Tissue Factor Pathway Inhibitor in a Rat Model of Streptococcus pneumoniae Pneumonia.
van den Boogaard FE; Hofstra JJ; van 't Veer C; Levi MM; Roelofs JJ; van der Poll T; Schultz MJ
PLoS One; 2015; 10(5):e0127261. PubMed ID: 25992779
[TBL] [Abstract][Full Text] [Related]
2. Nebulized Recombinant Human Tissue Factor Pathway Inhibitor Attenuates Coagulation and Exerts Modest Anti-inflammatory Effects in Rat Models of Lung Injury.
van den Boogaard FE; Hofstra JJ; Brands X; Levi MM; Roelofs JJ; Zaat SA; Van't Veer C; van der Poll T; Schultz MJ
J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):91-99. PubMed ID: 27977318
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia.
Van Den Boogaard FE; Brands X; Schultz MJ; Levi M; Roelofs JJ; Van 't Veer C; Van Der Poll T
J Thromb Haemost; 2011 Jan; 9(1):122-32. PubMed ID: 21029363
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats.
Choi G; Hofstra JJ; Roelofs JJ; Rijneveld AW; Bresser P; van der Zee JS; Florquin S; van der Poll T; Levi M; Schultz MJ
Crit Care Med; 2008 Jan; 36(1):204-10. PubMed ID: 18090375
[TBL] [Abstract][Full Text] [Related]
5. Endogenous tissue factor pathway inhibitor has a limited effect on host defence in murine pneumococcal pneumonia.
van den Boogaard FE; van 't Veer C; Roelofs JJ; Meijers JC; Schultz MJ; Broze GJ; van der Poll T
Thromb Haemost; 2015 Jul; 114(1):115-22. PubMed ID: 25832548
[TBL] [Abstract][Full Text] [Related]
6. Plasma-derived human antithrombin attenuates ventilator-induced coagulopathy but not inflammation in a Streptococcus pneumoniae pneumonia model in rats.
Aslami H; Haitsma JJ; Hofstra JJ; Florquin S; Dos Santos C; Streutker C; Zhang H; Levi M; Slutsky AS; Schultz MJ
J Thromb Haemost; 2012 Mar; 10(3):399-410. PubMed ID: 22236057
[TBL] [Abstract][Full Text] [Related]
7. Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia.
Rijneveld AW; Weijer S; Bresser P; Florquin S; Vlasuk GP; Rote WE; Spek CA; Reitsma PH; van der Zee JS; Levi M; van der Poll T
Crit Care Med; 2006 Jun; 34(6):1725-30. PubMed ID: 16625114
[TBL] [Abstract][Full Text] [Related]
8. Nebulized anticoagulants limit pulmonary coagulopathy, but not inflammation, in a model of experimental lung injury.
Hofstra JJ; Vlaar AP; Cornet AD; Dixon B; Roelofs JJ; Choi G; van der Poll T; Levi M; Schultz MJ
J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23(2):105-11. PubMed ID: 20073557
[TBL] [Abstract][Full Text] [Related]
9. Nebulized antithrombin limits bacterial outgrowth and lung injury in Streptococcus pneumoniae pneumonia in rats.
Hofstra JJ; Cornet AD; de Rooy BF; Vlaar AP; van der Poll T; Levi M; Zaat SA; Schultz MJ
Crit Care; 2009; 13(5):R145. PubMed ID: 19740417
[TBL] [Abstract][Full Text] [Related]
10. Nebulized anticoagulants limit coagulopathy but not inflammation in pseudomonas aeruginosa-induced pneumonia in rats.
Cornet AD; Hofstra JJ; Vlaar AP; van den Boogaard FE; Roelofs JJ; van der Poll T; Levi M; Groeneveld AB; Schultz MJ
Shock; 2011 Oct; 36(4):417-23. PubMed ID: 21897338
[TBL] [Abstract][Full Text] [Related]
11. Ventilator-induced coagulopathy in experimental Streptococcus pneumoniae pneumonia.
Haitsma JJ; Schultz MJ; Hofstra JJ; Kuiper JW; Juco J; Vaschetto R; Levi M; Zhang H; Slutsky AS
Eur Respir J; 2008 Dec; 32(6):1599-606. PubMed ID: 18768578
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa pneumonia in rats.
Choi G; Hofstra JJ; Roelofs JJ; Florquin S; Bresser P; Levi M; van der Poll T; Schultz MJ
Crit Care Med; 2007 May; 35(5):1362-8. PubMed ID: 17414732
[TBL] [Abstract][Full Text] [Related]
13. Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation.
Choi G; Vlaar AP; Schouten M; Van't Veer C; van der Poll T; Levi M; Schultz MJ
Eur Respir J; 2007 Sep; 30(3):423-8. PubMed ID: 17537762
[TBL] [Abstract][Full Text] [Related]
14. Plasma-derived human C1-esterase inhibitor does not prevent mechanical ventilation-induced pulmonary complement activation in a rat model of Streptococcus pneumoniae pneumonia.
de Beer FM; Aslami H; Hoeksma J; van Mierlo G; Wouters D; Zeerleder S; Roelofs JJ; Juffermans NP; Schultz MJ; Lagrand WK
Cell Biochem Biophys; 2014 Nov; 70(2):795-803. PubMed ID: 24760631
[TBL] [Abstract][Full Text] [Related]
15. Recombinant activated protein C attenuates coagulopathy and inflammation when administered early in murine pneumococcal pneumonia.
Schouten M; van 't Veer C; Roelofs JJ; Gerlitz B; Grinnell BW; Levi M; van der Poll T
Thromb Haemost; 2011 Dec; 106(6):1189-96. PubMed ID: 21901240
[TBL] [Abstract][Full Text] [Related]
16. Nebulized C1-Esterase Inhibitor does not Reduce Pulmonary Complement Activation in Rats with Severe Streptococcus Pneumoniae Pneumonia.
de Beer F; Lagrand W; Glas GJ; Beurskens CJ; van Mierlo G; Wouters D; Zeerleder S; Roelofs JJ; Juffermans NP; Horn J; Schultz MJ
Cell Biochem Biophys; 2016 Dec; 74(4):545-552. PubMed ID: 27683129
[TBL] [Abstract][Full Text] [Related]
17. A blinded trial of local recombinant tissue factor pathway inhibitor versus either local or systemic heparin in a vein bypass model.
Rapp JH; Pan XM; Ghermay A; Gazetas P; Brady SE; Reilly LM
J Vasc Surg; 1997 Apr; 25(4):726-9. PubMed ID: 9129630
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat.
Shirk RA; Zhang Z; Winneker RC
J Steroid Biochem Mol Biol; 2005 Mar; 94(4):361-8. PubMed ID: 15857755
[TBL] [Abstract][Full Text] [Related]
19. Induced hypothermia is protective in a rat model of pneumococcal pneumonia associated with increased adenosine triphosphate availability and turnover*.
Beurskens CJ; Aslami H; Kuipers MT; Horn J; Vroom MB; van Kuilenburg AB; Roelofs JJ; Schultz MJ; Juffermans NP
Crit Care Med; 2012 Mar; 40(3):919-26. PubMed ID: 22036856
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor pathway inhibitor and bacterial infection.
Maroney SA; Mast AE
J Thromb Haemost; 2011 Jan; 9(1):119-21. PubMed ID: 21210950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
